Resultados de búsqueda - Irina A. Kotikova

Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review por Amina M. Alieva, Natalia V. Teplova, Elena V. Reznik, Irina E. Baykova, Nyurzhanna Kh. Khadzhieva, Kira V. Voronkova, Irina V. Kovtiukh, Ramiz K. Valiev, Irina A. Kotikova, Igor G. Nikitin

Connect to this object online.

LOX-1 as a biological marker and therapeutic target in cardiovascular pathology (literature review) por Amina M. Alieva, Irina E. Baykova, Elena V. Reznik, Natalia V. Teplova, Ramiz K. Valiev, Malika Kh. Gyzyeva, Albina B. Sultangalieva, Irina A. Kotikova, Natalia A. Novikova, Sergey A. Korvyakov, Igor G. Nikitin

Connect to this object online.

Catestanin - a promising biological marker for heart failure: A review por Amina M. Alieva, Natalia V. Teplova, Elena V. Reznik, Olga A. Ettinger, Rashad A. Faradzhov, Elvira A. Khachirova, Irina V. Kovtiukh, Irina A. Kotikova, Diana A. Sysoeva, Il'dar R. Bigushev, Igor G. Nikitin

Connect to this object online.

Endocan is a key player in cardiovascular disease: A review por Amina M. Alieva, Elena V. Reznik, Irina E. Baykova, Natalia V. Teplova, Liudmila M. Makeeva, Kira V. Voronkova, Nyurzhanna Kh. Khadzhieva, Anna V. Modestova, Gaiane G. Totolyan, Ramiz K. Valiev, Alexander M. Li, Irina A. Kotikova, Igor G. Nikitin

Connect to this object online.